|Slideshows|October 28, 2020

10 Films About the Horrors of the Mind

Author(s)Fernando Espí Forcén, MD, PhD

The viewing of horror films, though paradoxical, can be therapeutic through sensation-seeking, catharsis, and existential relief of our deepest fears.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Psychiatrists Already Practice Comprehensive, Holistic Care—but More Resources Are Needed

ByJohn J. Miller, MD

May 8th 2026

Hotel Homicide, Hotel Suicide, and "The White Lotus"

BySusan Hatters Friedman, MD, MSt, DFAPA,Samuel Rosenblatt, MD

March 24th 2026

Brief Book Reviews: March 2026

ByEdmund S. Higgins, MD

March 17th 2026

A Review of How Psychiatrists Make Decisions: The Science of Clinical Reasoning

ByRonald W. Pies, MD

March 10th 2026

Keeping Up With the Ketamine: Psychiatric Diagnoses and Treatment on Reality TV

BySusan Hatters Friedman, MD, MSt, DFAPA,Nina E. Ross, MD,Kathleen L. Kruse, MD

February 16th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

10 Films About the Horrors of the Mind

Related Content

Psychiatrists Already Practice Comprehensive, Holistic Care—but More Resources Are Needed

Hotel Homicide, Hotel Suicide, and "The White Lotus"

Brief Book Reviews: March 2026

A Review of How Psychiatrists Make Decisions: The Science of Clinical Reasoning

Keeping Up With the Ketamine: Psychiatric Diagnoses and Treatment on Reality TV

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder

Phase 2 Analysis of ML-004 for Autism Spectrum Disorder Fails to Meet Endpoint

Celebrating the First APA Panel of Transgender Psychiatrists of Color: A Conversation With Emrys Fonseca, MD, MS

Psychiatric Pharmacogenomics: An Overview

Preventing Relapse in Schizophrenia: Focus on Women’s Mental Health